Vortioxetine Treatment for Depression in Alzheimer’s Disease: A Randomized, Double-blind, Placebo-controlled Study

OBJECTIVE: Vortioxetine, a new antidepressant, has been demonstrated to have effects on depression and cognitive function. This study aimed to investigate the anti-depressive efficacy of vortioxetine through a well-designed double-blind, placebo-controlled study in Alzheimer’s disease (AD) patients,...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeong, Hye Won, Yoon, Kyung Hee, Lee, Chang Hyun, Moon, Yoo Sun, Kim, Do Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean College of Neuropsychopharmacology 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9048008/
https://www.ncbi.nlm.nih.gov/pubmed/35466102
http://dx.doi.org/10.9758/cpn.2022.20.2.311

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9048008/
https://www.ncbi.nlm.nih.gov/pubmed/35466102
http://dx.doi.org/10.9758/cpn.2022.20.2.311

Ejemplares similares